GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,468.50p
   
  • Change Today:
    -20.00p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,293.50p
  • Currency: UK Pounds
  • Shares Issued: 4,129.58m
  • Volume: 1,247,074
  • Market Cap: £60,643m
  • RiskGrade: 129
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
4.11% below the market average4.11% below the market average4.11% below the market average4.11% below the market average4.11% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
1yr Revenue Growth
6.11% below the market average6.11% below the market average6.11% below the market average6.11% below the market average6.11% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
12.59% above the market average12.59% above the market average12.59% above the market average12.59% above the market average12.59% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
1yr DPS Growth
3.60% above the market average3.60% above the market average3.60% above the market average3.60% above the market average3.60% above the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
4.38% below the market average4.38% below the market average4.38% below the market average4.38% below the market average4.38% below the market average
64.29% below the sector average64.29% below the sector average64.29% below the sector average64.29% below the sector average64.29% below the sector average
Price Book Ratio
80.78% below the market average80.78% below the market average80.78% below the market average80.78% below the market average80.78% below the market average
44.19% below the sector average44.19% below the sector average44.19% below the sector average44.19% below the sector average44.19% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
52.89% above the market average52.89% above the market average52.89% above the market average52.89% above the market average52.89% above the market average
63.27% above the sector average63.27% above the sector average63.27% above the sector average63.27% above the sector average63.27% above the sector average
Price Chg 3m
69.32% above the market average69.32% above the market average69.32% above the market average69.32% above the market average69.32% above the market average
59.18% above the sector average59.18% above the sector average59.18% above the sector average59.18% above the sector average59.18% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
49.11% above the market average49.11% above the market average49.11% above the market average49.11% above the market average49.11% above the market average
78.26% above the sector average78.26% above the sector average78.26% above the sector average78.26% above the sector average78.26% above the sector average
Momentum 20
87.56% above the market average87.56% above the market average87.56% above the market average87.56% above the market average87.56% above the market average
86.96% above the sector average86.96% above the sector average86.96% above the sector average86.96% above the sector average86.96% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
19.23% above the market average19.23% above the market average19.23% above the market average19.23% above the market average19.23% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
ROCE
70.77% above the market average70.77% above the market average70.77% above the market average70.77% above the market average70.77% above the market average
Sector averageSector averageSector averageSector averageSector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
91.57% above the market average91.57% above the market average91.57% above the market average91.57% above the market average91.57% above the market average
91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average
Forecast EPS
78.77% above the market average78.77% above the market average78.77% above the market average78.77% above the market average78.77% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
97.84% above the market average97.84% above the market average97.84% above the market average97.84% above the market average97.84% above the market average
94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average
Operating Profit Loss
98.09% above the market average98.09% above the market average98.09% above the market average98.09% above the market average98.09% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
97.25% above the market average97.25% above the market average97.25% above the market average97.25% above the market average97.25% above the market average
95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average
Cash
96.83% above the market average96.83% above the market average96.83% above the market average96.83% above the market average96.83% above the market average
95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
72.49% above the market average72.49% above the market average72.49% above the market average72.49% above the market average72.49% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average
Buys 1y
99.33% above the market average99.33% above the market average99.33% above the market average99.33% above the market average99.33% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
95.89% below the market average95.89% below the market average95.89% below the market average95.89% below the market average95.89% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Brokers Percent Neutral
81.01% above the market average81.01% above the market average81.01% above the market average81.01% above the market average81.01% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,468.50p
Change Today -20.00p
% Change -1.34 %
52 Week High 1,812.50p
52 Week Low 1,293.50p
Volume 1,247,074
Shares Issued 4,129.58m
Market Cap £60,643m
Beta 0.01
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.97% below the market average66.97% below the market average66.97% below the market average66.97% below the market average66.97% below the market average
14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average
Price Trend
2.97% above the market average2.97% above the market average2.97% above the market average2.97% above the market average2.97% above the market average
30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average
Income
62.82% above the market average62.82% above the market average62.82% above the market average62.82% above the market average62.82% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
47.2% below the market average47.2% below the market average47.2% below the market average47.2% below the market average47.2% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 15
Sell 3
Strong Sell 0
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 20-Feb-25 14-Nov-24
Paid 10-Apr-25 09-Jan-25
Amount 16.00p 15.00p

Trades for 31-Mar-2025

Time Volume / Share Price
11:40 0 @ 1,468.50p
11:40 1,485 @ 1,468.50p
11:40 695 @ 1,468.50p
11:40 12 @ 1,468.50p
11:40 140 @ 1,468.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page